Biggest News Aggregation in the World
📰 Presenting Cells News

Presenting Cells News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Presenting Cells. Real-time updates on events, politics, business and more.

Short Interest in SQZ Biotechnologies (OTCMKTS:SQZB) Drops By 27.8%

SQZ Biotechnologies (OTCMKTS:SQZB – Get Free Report) was the recipient of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 23,100 shares, a decrease of 27.8% from the April 30th total of 32,000 shares. Based on an average daily trading volume, of 30,400 shares, […]
Biotechnologies Company Biotechnologies Company Profile Get Free Report Presenting Cells

SQZ Biotechnologies (NYSE:SQZ) versus Gamida Cell (NASDAQ:GMDA) Financial Survey

Gamida Cell (NASDAQ:GMDA – Get Free Report) and SQZ Biotechnologies (NYSE:SQZ – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, institutional ownership, risk, valuation and dividends. Earnings and Valuation This table compares Gamida […]
United States Israel General Biotechnologies Company Gamida Cell Ltd Gamida Cell Get Free Report

Head to Head Review: SQZ Biotechnologies (NYSE:SQZ) and Beam Therapeutics (NASDAQ:BEAM)

SQZ Biotechnologies (NYSE:SQZ – Free Report) and Beam Therapeutics (NASDAQ:BEAM – Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends. Valuation & Earnings This table compares SQZ Biotechnologies and Beam […]
United Kingdom United States Beam Therapeutics Inc Apellis Pharmaceuticals Institute Of Molecular Verve Therapeutics Inc

SQZ Biotechnologies Stock to Reverse Split on Friday, July 7th (NYSE:SQZ)

SQZ Biotechnologies (NYSE:SQZ – Free Report) shares are going to reverse split on Friday, July 7th. The 1-10 reverse split was announced on Friday, July 7th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, July 7th. SQZ Biotechnologies Price Performance SQZ Biotechnologies stock opened at $0.44 on […]
Charles Schwab Investment Management Inc Jpmorgan Chase Co Balyasny Asset Management Prudential Financial Inc Biotechnologies Company Free Report

Head to Head Contrast: SQZ Biotechnologies (NYSE:SQZ) & Beam Therapeutics (NASDAQ:BEAM)

SQZ Biotechnologies (NYSE:SQZ – Free Report) and Beam Therapeutics (NASDAQ:BEAM – Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends. Analyst Ratings This is a summary of current ratings and […]
United States United Kingdom Beam Therapeutics Inc Institute Of Molecular Sana Biotechnology Inc Pfizer Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

SQZ Biotechnologies (NYSE:SQZ) Shares Set to Reverse Split on Friday, July 7th

Shares of SQZ Biotechnologies (NYSE:SQZ – Free Report) are set to reverse split before the market opens on Friday, July 7th. The 1-10 reverse split was announced on Friday, July 7th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, July 7th. SQZ Biotechnologies Price Performance SQZ Biotechnologies […]
Prudential Financial Inc Balyasny Asset Management Biotechnologies Company Biotechnologies Company Profile Renaissance Technologies Free Report
Source: wkrb13.com

SQZ Biotechnologies (NYSE:SQZ) Shares Down 2.7%

SQZ Biotechnologies (NYSE:SQZ – Get Rating)’s share price dropped 2.7% during trading on Monday . The stock traded as low as $0.57 and last traded at $0.58. Approximately 34,327 shares traded hands during mid-day trading, a decline of 85% from the average daily volume of 230,793 shares. The stock had previously closed at $0.60. SQZ […]
Capital Management Charles Schwab Investment Management Inc Jpmorgan Chase Co Biotechnologies Company Profile Biotechnologies Company Citadel Advisors

Q2 2023 EPS Estimates for SQZ Biotechnologies (NYSE:SQZ) Decreased by HC Wainwright

SQZ Biotechnologies (NYSE:SQZ – Get Rating) – Investment analysts at HC Wainwright cut their Q2 2023 EPS estimates for shares of SQZ Biotechnologies in a report issued on Thursday, May 11th. HC Wainwright analyst E. Bodnar now anticipates that the company will post earnings of ($0.54) per share for the quarter, down from their previous […]
Renaissance Technologies Jpmorgan Chase Co Citadel Advisors Millennium Management Capital Management Biotechnologies Company Profile

Brookline Capital Management Equities Analysts Lift Earnings Estimates for SQZ Biotechnologies (NYSE:SQZ)

SQZ Biotechnologies (NYSE:SQZ – Get Rating) – Equities research analysts at Brookline Capital Management increased their FY2026 EPS estimates for shares of SQZ Biotechnologies in a report released on Wednesday, May 10th. Brookline Capital Management analyst L. Cann now forecasts that the company will post earnings of $17.70 per share for the year, up from […]
Citadel Advisors Millennium Management Jpmorgan Chase Co Charles Schwab Investment Management Inc Biotechnologies Company Renaissance Technologies

SQZ Biotechnologies (NYSE:SQZ) Trading Down 5.8%

SQZ Biotechnologies (NYSE:SQZ – Get Rating)’s share price traded down 5.8% during mid-day trading on Thursday . The stock traded as low as $0.58 and last traded at $0.60. 56,120 shares were traded during trading, a decline of 79% from the average session volume of 267,070 shares. The stock had previously closed at $0.64. SQZ […]
Balyasny Asset Management Renaissance Technologies Biotechnologies Company Prudential Financial Inc Get Rating Asset Management

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science